Saltar al contenido
Merck

Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Stem cells translational medicine (2014-03-22)
Hong-Kee Tan, Cheng-Xu Delon Toh, Dongrui Ma, Binxia Yang, Tong Ming Liu, Jun Lu, Chee-Wai Wong, Tze-Kai Tan, Hu Li, Christopher Syn, Eng-Lee Tan, Bing Lim, Yoon-Pin Lim, Stuart A Cook, Yuin-Han Loh
RESUMEN

Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish human iPSC (hiPSC) banking face challenges in recruiting large numbers of donors with diverse diseased, genetic, and phenotypic representations. In this study, we describe the efficient derivation of transgene-free hiPSCs from human finger-prick blood. Finger-prick sample collection can be performed on a "do-it-yourself" basis by donors and sent to the hiPSC facility for reprogramming. We show that single-drop volumes of finger-prick samples are sufficient for performing cellular reprogramming, DNA sequencing, and blood serotyping in parallel. Our novel strategy has the potential to facilitate the development of large-scale hiPSC banking worldwide.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-α-actinina (sarcomérica) monoclonal antibody produced in mouse, clone EA-53, ascites fluid
Sigma-Aldrich
Anti-Glial Fibrillary Acidic Protein antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-Titin Antibody, clone 9B9, culture supernatant, clone 9B9, Chemicon®